Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis

This study has been terminated.
(No plan to continue enrollment)
Sponsor:
Information provided by (Responsible Party):
Richard Burt, MD, Northwestern University
ClinicalTrials.gov Identifier:
NCT00282438
First received: January 24, 2006
Last updated: March 21, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2015
  Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)